Mitchell Machtay

20.4k citations

299 papers · 14.3k indexed · 5 hit papers · h-index 56

Impact in

Otorhinolaryngology top 0.01%
- Head and Neck Cancer Studies
Radiation top 0.1%
- Advanced Radiotherapy Techniques

Papers in

Otorhinolaryngology 92
- Head and Neck Cancer Studies 92
Radiation 74
- Advanced Radiotherapy Techniques 74

Co-authors: Randal S. Weber Jay S. Cooper Arlene A. Forastiere David I. Rosenthal William T. Sause Christopher J. Schultz Walter J. Curran Marvin Rotman
Journals: International Journal of Radiation Oncology*Biology*Physics (101 papers)Journal of Clinical Oncology (37 papers)Medical Physics (11 papers)Radiotherapy and Oncology (9 papers)Head & Neck (7 papers)
Partner nations: United States Canada China

In The Last Decade

Mitchell Machtay

291 papers receiving 14.0k citations

Hit Papers

5 papers align trajectories log scale

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410 2011 · 876 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 JNCI Journal of the National Cancer Institute
2008 Journal of Clinical Oncology
2004 New England Journal of Medicine
2003 Journal of Clinical Oncology
2001 International Journal of Radiation Oncology*Biology*Physics

Peers

Countries citing papers authored by Mitchell Machtay

Since Specialization

Citations

This map shows the geographic impact of Mitchell Machtay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Machtay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Machtay more than expected).

Fields of papers citing papers by Mitchell Machtay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Machtay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Machtay. The network helps show where Mitchell Machtay may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell Machtay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell Machtay Line = papers co-authored together Mitchell Machtay links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Phase II Randomized Trial of Radical Resection vs. Stereotactic Body Radiation Therapy (SBRT) in Patients with Operable Stage I Non-Small Cell Lung Cancer (NSCLC): Final Report Of RTOG-F3502 International Journal of Radiation OncologyBiologyPhysics ·Feng‐Ming Kong, Jinming Yu, James J. Dignam, Yamanaka Shin'ichi, Chen Hu, Yun Xiao, محمود سجادی, Andrew C. Chang, Mark B. Orringer, T. D’Amico, F Yin, Ning J. Yue, Weimin Mao, Kuaile Zhao, Beatriz-Raquel Tendler, Elissa Ledvort, Mitchell Machtay	2024	1
2	A Novel Mechanistic Cell Survival Model to Replace Linear-Quadratic Model for Relative Biological Effectiveness (RBE) in Proton Therapy International Journal of Radiation OncologyBiologyPhysics ·Jian Jin, Alexander M. Vo, Nancy L. Oleinick, Min Yao, Quintin Pan, Feng‐Ming Kong, Mitchell Machtay	2021	1
3	Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies JNCI Cancer Spectrum ·Leila T. Tchelebi, Bárbara Cárdenas Torres, Ming Wang, Eric J. Lehrer, Joseph J. Drabick, Navesh Sharma, Mitchell Machtay, Daniel M. Trifiletti, Nicholas G. Zaorsky	2021	15
4	Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617 Cancers ·Jian‐Yue Jin, Chen Hu, Ying Xiao, Hong Zhang, Rebecca Paulus, Susannah G. Ellsworth, Steven E. Schild, Jeffrey A. Bogart, M.C. Dobelbower, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Clifford G. Robinson, Joel S. Greenberger, Christopher D. Koprowski, Mitchell Machtay, Walter J. Curran, Hak Choy, Jeffrey D. Bradley, Feng‐Ming Kong	2021	66
5	Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning Frontiers in Oncology ·香滋高, Bryan Traughber, Michael Kharouta, Tarun K. Podder, Simon S. Lo, Lee Ponsky, Gregory T. MacLennan, Raj Mohan Paspulati, María Julieta Thomé, Mitchell Machtay, Rodney J. Ellis	2021	3
6	RTOG0617 to Externally Validate Blood Cell ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Both Tumor and Normal Tissue for Individualized Dose Prescription International Journal of Radiation OncologyBiologyPhysics ·Feng‐Ming Kong, Filipe Mesquita, Chen Hu, Weili Wang, Jeffrey A. Bogart, Yolanda I. Garces, Samir Narayan, Clifford G. Robinson, Vivek S. Kavadi, Philippe Bissara, Christopher D. Koprowski, Elizabeth Gore, James W. Welsh, Rakesh Gaur, Robert M. MacRae, George M. Cannon, Mitchell Machtay, Jeffrey D. Bradley, Bo Lü	2020	3
7	A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease Clinical Cancer Research ·Weili Wang, Lei Huang, Jian‐Yue Jin, Wenhu Pi, Susannah G. Ellsworth, Shruti Jolly, Andrew L. Mellor, Mitchell Machtay, Feng‐Ming Kong	2019	22
8	Evaluating radiotherapy treatment delay using Failure Mode and Effects Analysis (FMEA) Radiotherapy and Oncology ·Zhengzheng Xu, Atousa Ali Ahmadi, Paul D. Kaplan, 智博田崎, Rodney J. Ellis, Tithi Biswas, Mitchell Machtay, Tarun K. Podder	2019	19
9	Enhanced Radiosensitization of Lung Adenocarcinoma Cells by Pemetrexed When Combined With Methoxyamine to Inhibit Base Excision Repair International Journal of Radiation OncologyBiologyPhysics ·Tithi Biswas, Ravi B. Patel, Lachelle D. Weeks, 安西桃子, Afshin Dowlati, Neelesh Sharma, Nancy L. Oleinick, S L Gerson, Mitchell Machtay	2013	0
10	Comparison Between IMRT and 3D CRT in Laryngeal Cancer Patients Treated on RTOG 0522 International Journal of Radiation OncologyBiologyPhysics ·Charles R. Woods, Wolfram Rupp, Craig L. Silverman, George Shenouda, Jonathan Harris, K. Kian Ang, Mitchell Machtay	2013	1
11	Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors Acta Oncologica ·R Ibarra, Roshini Nandagopal, Laura L. Snyder, Min Yao, J Poincenot, Michael T. Milano, Alan W. Katz, Karyn A. Goodman, Kevin L. Stephans, Galal El‐Gazzaz, Federico Aucejo, Soheb Balkh, John J. Fung, Simon S. Lo, Mitchell Machtay, Juan Sanabria	2012	69
12	Stereotactic body radiation therapy for metastasis to the adrenal glands Expert Review of Anticancer Therapy ·Kevin Shiue, Andrew Song, Bin S. Teh, Rodney J. Ellis, Min Yao, Nina A. Mayr, Zhibin Huang, Jason W. Sohn, Mitchell Machtay, Simon S. Lo	2012	10
13	Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials Radiotherapy and Oncology ·Christopher G. Willett, Jennifer Moughan, Elizabeth O’Meara, James M. Galvin, Christopher H. Crane, Kathryn Winter, Селезнева Алена Владимировна, Tyvin A. Rich, Rachel Rabinovitch, Robert A. Lustig, Mitchell Machtay, Walter J. Curran	2012	21
14	Daily Image Guidance With Cone-Beam Computed Tomography for Head-and-Neck Cancer Intensity-Modulated Radiotherapy: A Prospective Study International Journal of Radiation OncologyBiologyPhysics ·Robert B. Den, Anthony Doemer, Hannah R. Ebin, Greg Bednarz, James M. Galvin, William M. Keane, Ying Xiao, Mitchell Machtay	2009	116
15	Pretreatment FDG‐PET standardized uptake value as a prognostic factor for outcome in head and neck cancer Head & Neck ·Mitchell Machtay, J Perek, Jocelyn Andrel, Terry Hyslop, P.R. Anné, VALERY WALKER, Charles Intenzo, William M. Keane	2008	86
16	Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer International Journal of Radiation OncologyBiologyPhysics ·Mitchell Machtay, David I. Rosenthal, Ara A. Chalian, Sevara Baratova, Diáne Hershock, Linda Miller, Gregory S. Weinstein, Randal S. Weber	2004	57
17	Pathological Response to Preoperative Chemoradiation Worsens with Anemia in Non---Small Cell Lung Cancer Patients The Cancer Journal ·Theodore J. Robnett, Mitchell Machtay, Stephen M. Hahn, Joseph B. Shrager, Joseph S. Friedberg, Larry R. Kaiser	2002	18
18	Androgen ablation adjuvant to defintive radiotherapy in carcinoma of the prostate: year 2000 update of RTOG phase III studies 86-10 and 85-31 International Journal of Radiation OncologyBiologyPhysics ·M.V. Pilepich, 何琪, Roger W. Byhardt, J Mesić, Mitchell Machtay, Gerald E. Hanks, Majnu John, William T. Sause	2000	7
19	Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer International Journal of Radiation OncologyBiologyPhysics ·Theodore J. Robnett, Mitchell Machtay, Al Galaburda, Michael G. McKenna, Kenneth M. Algazy, W. Gillies McKenna	2000	234
20	Pilot Study of Organ Preservation Multimodality Therapy for Locally Advanced Resectable Oropharyngeal Carcinoma American Journal of Clinical Oncology ·Mitchell Machtay, David I. Rosenthal, Kenneth M. Algazy, Budi Handiono, Ara A. Chalian, Diáne Hershock, Robin Neubauer, Michael J. Greenberg, Natasha Mirza, Gregory S. Weinstein, Randal S. Weber	2000	13

About Mitchell Machtay

Mitchell Machtay is a scholar working on Otorhinolaryngology, Radiation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 299 papers that have together received 14.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (92 papers), Lung Cancer Treatments and Mutations (77 papers), Advanced Radiotherapy Techniques (74 papers), Lung Cancer Diagnosis and Treatment (71 papers), Lung Cancer Research Studies (40 papers), Medical Imaging Techniques and Applications (36 papers), Radiomics and Machine Learning in Medical Imaging (32 papers) and Brain Metastases and Treatment (26 papers). The work is most often cited by research in Otorhinolaryngology (5.4k citations), Radiation (2.6k citations), Pulmonary and Respiratory Medicine (7.9k citations), Oncology (4.1k citations) and Radiology, Nuclear Medicine and Imaging (2.8k citations). Mitchell Machtay has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, David I. Rosenthal, William T. Sause, Christopher J. Schultz, Walter J. Curran, Marvin Rotman, Jennifer Moughan and Anthony J. Cmelak. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Medical Physics, Radiotherapy and Oncology and Head & Neck.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact